Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Banshi Saboo

Showing results (11-20 of 195) with videos related to

Pageof 20
Sort By:
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|May 1, 2015
Saroglitazar for the treatment of hypertrig-lyceridemia in patients with type 2 diabetes: current evidenceAravind Sosale, Banshi Saboo, Bhavana Sosale
The Journal of the Association of Physicians of India|February 4, 2014
Current glycemic status and diabetes related complications among type 2 diabetes patients in India: data from the A1chieve studyViswanathan Mohan, Siddharth Shah, Banshi Saboo
Diabetes & Metabolic Syndrome|January 25, 2022
A prospective multicentre open label study to assess effect of Teneligliptin on glycemic control through parameters of time in range (TIR) Metric using continuous glucose monitoring (TOP-TIR study)Banshi Saboo, Suhas Erande, A G Unnikrishnan
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|June 24, 2021
Current Practices and Gaps in Management of Dyslipidemia in Type 2 Diabetes Mellitus (T2DM) in Accordance with American Diabetes Association (ADA) Guidelines: A Subset Analysis from a Real-World, Cross-Sectional Observational Study (LEADD Study)Ashok Kumar Das, Banshi Saboo, Ambika G Unnikrishnan
International Journal of Diabetes in Developing Countries|December 20, 2022
RSSDI Guidelines for the management of hypertension in patients with diabetes mellitusVasanth Kumar, Sanjay Agarwal, Banshi Saboo, et al.
Comprehensive Physiology|April 29, 2026
The Mitochondrial-Autophagy Axis in MASLD: Mechanisms, Crosstalk, and Therapeutic TargetsGaurab Bhaduri, Anchin Kalia, Banshi Saboo, et al.
Diabetes & Metabolic Syndrome|September 6, 2021
QTc prolongation Safety and Effectiveness of Teneligliptin in Indian patients with type 2 Diabetes Mellitus: A real world study (QSET 2)Banshi Saboo, Sujoy Ghosh, Mangesh Tiwaskar, et al.
Diabetes & Metabolic Syndrome|March 16, 2021
DIY artificial pancreas: A narrative of the first patient and the physicians' experiences from IndiaJothydev Kesavadev, Banshi Saboo, Partha Kar, et al.
Diabetes & Metabolic Syndrome|September 21, 2017
Multiple educational programs improves glycemic control, quality of life with diminishing the impact of diabetes in poorly controlled type 1 diabeticsChintan Vyas, Lopa Dalal, Praful Talaviya, et al.
Diabetes & Metabolic Syndrome|December 22, 2020
Non-insulin anti-diabetic agents in patients with type 2 diabetes and COVID-19: A Critical Appraisal of LiteratureAwadhesh Kumar Singh, Ritu Singh, Banshi Saboo, et al.
Pageof 20

Showing results (11-20 of 195) with videos related to

Sort By:
Pageof 20
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|May 1, 2015
Saroglitazar for the treatment of hypertrig-lyceridemia in patients with type 2 diabetes: current evidenceAravind Sosale, Banshi Saboo, Bhavana Sosale
The Journal of the Association of Physicians of India|February 4, 2014
Current glycemic status and diabetes related complications among type 2 diabetes patients in India: data from the A1chieve studyViswanathan Mohan, Siddharth Shah, Banshi Saboo
Diabetes & Metabolic Syndrome|January 25, 2022
A prospective multicentre open label study to assess effect of Teneligliptin on glycemic control through parameters of time in range (TIR) Metric using continuous glucose monitoring (TOP-TIR study)Banshi Saboo, Suhas Erande, A G Unnikrishnan
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|June 24, 2021
Current Practices and Gaps in Management of Dyslipidemia in Type 2 Diabetes Mellitus (T2DM) in Accordance with American Diabetes Association (ADA) Guidelines: A Subset Analysis from a Real-World, Cross-Sectional Observational Study (LEADD Study)Ashok Kumar Das, Banshi Saboo, Ambika G Unnikrishnan
International Journal of Diabetes in Developing Countries|December 20, 2022
RSSDI Guidelines for the management of hypertension in patients with diabetes mellitusVasanth Kumar, Sanjay Agarwal, Banshi Saboo, et al.
Comprehensive Physiology|April 29, 2026
The Mitochondrial-Autophagy Axis in MASLD: Mechanisms, Crosstalk, and Therapeutic TargetsGaurab Bhaduri, Anchin Kalia, Banshi Saboo, et al.
Diabetes & Metabolic Syndrome|September 6, 2021
QTc prolongation Safety and Effectiveness of Teneligliptin in Indian patients with type 2 Diabetes Mellitus: A real world study (QSET 2)Banshi Saboo, Sujoy Ghosh, Mangesh Tiwaskar, et al.
Diabetes & Metabolic Syndrome|March 16, 2021
DIY artificial pancreas: A narrative of the first patient and the physicians' experiences from IndiaJothydev Kesavadev, Banshi Saboo, Partha Kar, et al.
Diabetes & Metabolic Syndrome|September 21, 2017
Multiple educational programs improves glycemic control, quality of life with diminishing the impact of diabetes in poorly controlled type 1 diabeticsChintan Vyas, Lopa Dalal, Praful Talaviya, et al.
Diabetes & Metabolic Syndrome|December 22, 2020
Non-insulin anti-diabetic agents in patients with type 2 diabetes and COVID-19: A Critical Appraisal of LiteratureAwadhesh Kumar Singh, Ritu Singh, Banshi Saboo, et al.
Pageof 20